Get Live Data

The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Shire Share Price
  4. Shire Share Regulatory News
  5. Form 8.3 - SHIRE PLC - AMENDMENT

Pin to quick picksShire Regulatory News (SHP)

Shire Information
  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SHIRE PLC - AMENDMENT

18 Dec 2018 13:59

FORM 8.3 Amendment to Sales

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose SHIRE PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 14 December 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? TAKEDA PHARMACEUTICAL CO LTD

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 5p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 6,388,721 0.70% 5,323,424 0.58%
(2) Cash-settled derivatives:
313,802 0.03% 3,989,558 0.44%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 1,098,900 0.12% 937,700 0.10%
TOTAL: 7,801,423 0.85% 10,250,682 1.12%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
5p ordinary Purchase 37 46.5350 GBP
5p ordinary Purchase 39 46.4450 GBP
5p ordinary Purchase 43 46.4300 GBP
5p ordinary Purchase 44 46.4200 GBP
5p ordinary Purchase 50 46.5200 GBP
5p ordinary Purchase 50 46.4400 GBP
5p ordinary Purchase 63 46.4750 GBP
5p ordinary Purchase 96 46.5100 GBP
5p ordinary Purchase 128 46.5150 GBP
5p ordinary Purchase 172 46.5360 GBP
5p ordinary Purchase 180 46.6825 GBP
5p ordinary Purchase 291 46.6780 GBP
5p ordinary Purchase 330 46.7149 GBP
5p ordinary Purchase 890 46.7300 GBP
5p ordinary Purchase 1,120 46.6758 GBP
5p ordinary Purchase 1,135 46.6526 GBP
5p ordinary Purchase 1,562 46.6810 GBP
5p ordinary Purchase 2,813 46.6390 GBP
5p ordinary Purchase 3,578 46.8150 GBP
5p ordinary Purchase 5,000 46.6582 GBP
5p ordinary Purchase 7,075 46.5038 GBP
5p ordinary Purchase 8,021 46.6376 GBP
5p ordinary Purchase 8,161 46.7005 GBP
5p ordinary Purchase 19,880 46.6898 GBP
5p ordinary Purchase 63,118 46.4773 GBP
5p ordinary Purchase 305,355 46.5199 GBP
5p ordinary Purchase 491,313 46.3000 GBP
5p ordinary Purchase 603,807 46.2999 GBP
5p ordinary Sale 37 46.5350 GBP
5p ordinary Sale 39 46.4450 GBP
5p ordinary Sale 43 46.4300 GBP
5p ordinary Sale 44 46.4200 GBP
5p ordinary Sale 50 46.4400 GBP
5p ordinary Sale 63 46.4750 GBP
5p ordinary Sale 66 46.6150 GBP
5p ordinary Sale 96 46.5100 GBP
5p ordinary Sale 128 46.5150 GBP
5p ordinary Sale 345 46.6860 GBP
5p ordinary Sale 376 46.5117 GBP
5p ordinary Sale 947 46.5344 GBP
5p ordinary Sale 1,477 46.6171 GBP
5p ordinary Sale 2,067 46.7308 GBP
5p ordinary Sale 4,174 46.4870 GBP
5p ordinary Sale 4,310 46.7142 GBP
5p ordinary Sale 8,486 46.7243 GBP
5p ordinary Sale 34,218 46.7221 GBP
5p ordinary Sale 40,462 46.6759 GBP
5p ordinary Sale 68,571 46.6438 GBP
5p ordinary Sale 274,620 46.5091 GBP
5p ordinary Sale 1,386,333 46.7300 GBP
5p ordinary Sale 1,597,450 46.5200 GBP
ADR Purchase 100 176.4100 USD
ADR Purchase 100 175.0100 USD
ADR Purchase 112 175.9346 USD
ADR Purchase 200 174.9250 USD
ADR Purchase 200 175.4500 USD
ADR Purchase 200 175.3800 USD
ADR Purchase 300 176.1475 USD
ADR Purchase 300 175.9800 USD
ADR Purchase 300 175.4866 USD
ADR Purchase 400 175.1112 USD
ADR Purchase 400 175.7725 USD
ADR Purchase 400 175.7175 USD
ADR Purchase 400 176.1000 USD
ADR Purchase 500 175.4140 USD
ADR Purchase 600 175.8758 USD
ADR Purchase 800 176.0562 USD
ADR Purchase 981 174.9500 USD
ADR Purchase 1,100 175.9454 USD
ADR Purchase 1,194 175.7000 USD
ADR Purchase 1,300 175.3780 USD
ADR Purchase 1,388 175.8096 USD
ADR Purchase 1,400 175.6157 USD
ADR Purchase 1,400 176.0028 USD
ADR Purchase 1,432 176.1006 USD
ADR Purchase 1,500 175.3603 USD
ADR Purchase 2,468 175.5003 USD
ADR Purchase 2,900 175.9456 USD
ADR Purchase 3,500 175.7920 USD
ADR Purchase 4,141 175.6859 USD
ADR Purchase 5,756 175.6769 USD
ADR Purchase 8,600 176.2334 USD
ADR Purchase 12,169 176.0758 USD
ADR Purchase 21,039 175.3720 USD
ADR Sale 70 175.7300 USD
ADR Sale 100 176.1500 USD
ADR Sale 100 175.1900 USD
ADR Sale 100 175.1300 USD
ADR Sale 100 175.1800 USD
ADR Sale 170 175.8758 USD
ADR Sale 200 174.9250 USD
ADR Sale 216 175.9552 USD
ADR Sale 300 175.9733 USD
ADR Sale 300 175.8250 USD
ADR Sale 350 176.2600 USD
ADR Sale 369 176.2745 USD
ADR Sale 500 175.1520 USD
ADR Sale 500 172.5000 USD
ADR Sale 600 175.3458 USD
ADR Sale 700 175.6785 USD
ADR Sale 701 175.5240 USD
ADR Sale 735 175.5435 USD
ADR Sale 981 174.9500 USD
ADR Sale 1,000 175.3350 USD
ADR Sale 1,001 175.4395 USD
ADR Sale 1,100 175.3490 USD
ADR Sale 1,194 175.7000 USD
ADR Sale 1,300 175.3780 USD
ADR Sale 1,496 176.0217 USD
ADR Sale 1,659 175.2515 USD
ADR Sale 1,900 175.6986 USD
ADR Sale 1,999 175.2987 USD
ADR Sale 2,200 176.0922 USD
ADR Sale 2,800 175.6846 USD
ADR Sale 3,200 175.6140 USD
ADR Sale 3,969 175.3433 USD
ADR Sale 4,015 175.3910 USD
ADR Sale 4,237 175.5893 USD
ADR Sale 5,149 175.3744 USD
ADR Sale 6,000 175.7134 USD
ADR Sale 8,600 176.2334 USD
ADR Sale 18,269 176.0082 USD
ADR Sale 21,039 175.3720 USD

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
5p ordinary CFD Long 143 46.7723 GBP
5p ordinary CFD Long 300 46.8054 GBP
5p ordinary CFD Long 1,800 46.5830 GBP
5p ordinary CFD Long 2,067 46.7308 GBP
5p ordinary CFD Long 4,167 46.7122 GBP
5p ordinary CFD Long 4,174 46.4870 GBP
5p ordinary SWAP Long 6,233 46.6839 GBP
5p ordinary SWAP Long 7,024 46.5152 GBP
5p ordinary CFD Long 34,218 46.7221 GBP
5p ordinary SWAP Long 67,049 46.6131 GBP
5p ordinary SWAP Long 1,395,810 46.7300 GBP
5p ordinary CFD Long 1,597,400 46.5200 GBP
5p ordinary SWAP Short 165 46.7498 GBP
5p ordinary CFD Short 172 46.5360 GBP
5p ordinary CFD Short 440 46.7770 GBP
5p ordinary SWAP Short 550 46.4853 GBP
5p ordinary SWAP Short 1,812 46.6306 GBP
5p ordinary CFD Short 6,666 46.7342 GBP
5p ordinary CFD Short 7,075 46.5038 GBP
5p ordinary SWAP Short 21,817 46.5782 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
ADR Call Options Purchasing 400 175 USD American 18 Apr 2019 7.3000 USD
ADR Call Options Purchasing 4,100 180 USD American 21 Dec 2018 0.4134 USD
ADR Put Options Purchasing 4,100 168 USD American 21 Dec 2018 0.3058 USD
ADR Put Options Purchasing 2,500 170 USD American 18 Jan 2019 2.3000 USD
ADR Put Options Purchasing 2,500 175 USD American 18 Jan 2019 3.7000 USD
ADR Put Options Selling 2,700 125 USD American 18 Jan 2019 0.1500 USD
ADR Put Options Selling 2,500 135 USD American 18 Jan 2019 0.2100 USD
ADR Put Options Selling 1,000 155 USD American 18 Jan 2019 0.7000 USD

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 18 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose SHIRE PLC
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
5p ordinary Call Options Written -125,000 3600.0000 American 21 Dec 2018
5p ordinary Put Options Written 125,000 3600.0000 American 21 Dec 2018
ADR Call Options Purchased 100 155.0000 American 15 Jan 2021
ADR Call Options Purchased 100 220.0000 American 18 Jan 2019
ADR Call Options Purchased 100 180.0000 American 18 Apr 2019
ADR Call Options Purchased 100 190.0000 American 4 Jan 2019
ADR Call Options Purchased 100 140.0000 American 18 Jan 2019
ADR Call Options Purchased 100 105.0000 American 18 Jan 2019
ADR Call Options Purchased 100 195.0000 American 19 Jul 2019
ADR Call Options Purchased 100 110.0000 American 17 Jan 2020
ADR Call Options Purchased 200 155.0000 American 17 Jan 2020
ADR Call Options Purchased 200 210.0000 American 18 Jan 2019
ADR Call Options Purchased 200 120.0000 American 17 Jan 2020
ADR Call Options Purchased 200 160.0000 American 17 Jan 2020
ADR Call Options Purchased 200 130.0000 American 17 Jan 2020
ADR Call Options Purchased 200 135.0000 American 17 Jan 2020
ADR Call Options Purchased 300 115.0000 American 18 Jan 2019
ADR Call Options Purchased 300 165.0000 American 18 Jan 2019
ADR Call Options Purchased 400 170.0000 American 17 Jan 2020
ADR Call Options Purchased 400 230.0000 American 18 Jan 2019
ADR Call Options Purchased 500 150.0000 American 18 Jan 2019
ADR Call Options Purchased 900 195.0000 American 18 Apr 2019
ADR Call Options Purchased 1,000 180.0000 American 17 Jan 2020
ADR Call Options Purchased 1,000 190.0000 American 11 Jan 2019
ADR Call Options Purchased 1,000 135.0000 American 18 Jan 2019
ADR Call Options Purchased 1,000 170.0000 American 19 Jul 2019
ADR Call Options Purchased 1,000 185.0000 American 19 Jul 2019
ADR Call Options Purchased 1,500 230.0000 American 15 Jan 2021
ADR Call Options Purchased 1,700 175.0000 American 18 Jan 2019
ADR Call Options Purchased 1,700 195.0000 American 17 Jan 2020
ADR Call Options Purchased 2,000 150.0000 American 17 Jan 2020
ADR Call Options Purchased 2,000 165.0000 American 18 Apr 2019
ADR Call Options Purchased 2,100 190.0000 American 18 Apr 2019
ADR Call Options Purchased 2,300 175.0000 American 18 Apr 2019
ADR Call Options Purchased 2,600 185.0000 American 18 Apr 2019
ADR Call Options Purchased 3,100 155.0000 American 18 Jan 2019
ADR Call Options Purchased 3,800 125.0000 American 18 Jan 2019
ADR Call Options Purchased 4,300 170.0000 American 18 Apr 2019
ADR Call Options Purchased 5,000 180.0000 American 21 Dec 2018
ADR Call Options Purchased 5,700 160.0000 American 19 Jul 2019
ADR Call Options Purchased 6,000 193.0000 American 21 Dec 2018
ADR Call Options Purchased 7,200 173.0000 American 21 Dec 2018
ADR Call Options Purchased 7,700 155.0000 American 18 Apr 2019
ADR Call Options Purchased 8,500 185.0000 American 21 Dec 2018
ADR Call Options Purchased 9,200 200.0000 American 15 Jan 2021
ADR Call Options Purchased 9,600 170.0000 American 18 Jan 2019
ADR Call Options Purchased 12,100 175.0000 American 21 Dec 2018
ADR Call Options Purchased 18,200 160.0000 American 18 Jan 2019
ADR Call Options Purchased 20,300 190.0000 American 21 Dec 2018
ADR Call Options Purchased 22,300 200.0000 American 18 Jan 2019
ADR Call Options Purchased 23,900 195.0000 American 18 Jan 2019
ADR Call Options Purchased 138,700 190.0000 American 18 Jan 2019
ADR Call Options Written -56,000 200.0000 American 17 Jan 2020
ADR Call Options Written -42,400 200.0000 American 19 Jul 2019
ADR Call Options Written -33,100 185.0000 American 18 Jan 2019
ADR Call Options Written -31,000 180.0000 American 18 Jan 2019
ADR Call Options Written -22,500 190.0000 American 21 Dec 2018
ADR Call Options Written -11,700 165.0000 American 21 Dec 2018
ADR Call Options Written -11,500 185.0000 American 21 Dec 2018
ADR Call Options Written -5,000 178.0000 American 21 Dec 2018
ADR Call Options Written -3,800 170.0000 American 21 Dec 2018
ADR Call Options Written -2,700 145.0000 American 18 Jan 2019
ADR Call Options Written -2,400 130.0000 American 18 Jan 2019
ADR Call Options Written -1,500 210.0000 American 19 Jul 2019
ADR Call Options Written -1,000 85.0000 American 18 Jan 2019
ADR Call Options Written -1,000 210.0000 American 21 Dec 2018
ADR Call Options Written -800 155.0000 American 18 Apr 2019
ADR Call Options Written -600 160.0000 American 18 Jan 2019
ADR Call Options Written -500 160.0000 American 18 Apr 2019
ADR Call Options Written -500 135.0000 American 19 Jul 2019
ADR Call Options Written -500 173.0000 American 14 Dec 2018
ADR Call Options Written -100 140.0000 American 17 Jan 2020
ADR Call Options Written -100 150.0000 American 18 Apr 2019
ADR Put Options Purchased -277,200 165.0000 American 18 Jan 2019
ADR Put Options Purchased -157,900 165.0000 American 21 Dec 2018
ADR Put Options Purchased -41,400 135.0000 American 18 Jan 2019
ADR Put Options Purchased -23,600 170.0000 American 21 Dec 2018
ADR Put Options Purchased -15,200 160.0000 American 18 Apr 2019
ADR Put Options Purchased -7,300 170.0000 American 14 Dec 2018
ADR Put Options Purchased -5,900 180.0000 American 18 Jan 2019
ADR Put Options Purchased -5,300 165.0000 American 15 Jan 2021
ADR Put Options Purchased -3,800 168.0000 American 21 Dec 2018
ADR Put Options Purchased -3,700 145.0000 American 21 Dec 2018
ADR Put Options Purchased -3,700 145.0000 American 17 Jan 2020
ADR Put Options Purchased -3,600 155.0000 American 18 Jan 2019
ADR Put Options Purchased -3,500 140.0000 American 18 Jan 2019
ADR Put Options Purchased -2,900 170.0000 American 18 Jan 2019
ADR Put Options Purchased -2,900 175.0000 American 18 Jan 2019
ADR Put Options Purchased -2,700 80.0000 American 18 Jan 2019
ADR Put Options Purchased -2,500 160.0000 American 15 Jan 2021
ADR Put Options Purchased -2,500 120.0000 American 17 Jan 2020
ADR Put Options Purchased -2,300 85.0000 American 18 Jan 2019
ADR Put Options Purchased -2,000 130.0000 American 15 Jan 2021
ADR Put Options Purchased -2,000 80.0000 American 17 Jan 2020
ADR Put Options Purchased -1,800 115.0000 American 18 Jan 2019
ADR Put Options Purchased -1,700 160.0000 American 17 Jan 2020
ADR Put Options Purchased -1,400 165.0000 American 17 Jan 2020
ADR Put Options Purchased -1,200 135.0000 American 17 Jan 2020
ADR Put Options Purchased -1,100 70.0000 American 17 Jan 2020
ADR Put Options Purchased -1,000 155.0000 American 15 Jan 2021
ADR Put Options Purchased -1,000 170.0000 American 17 Jan 2020
ADR Put Options Purchased -800 150.0000 American 17 Jan 2020
ADR Put Options Purchased -600 180.0000 American 18 Apr 2019
ADR Put Options Purchased -500 140.0000 American 17 Jan 2020
ADR Put Options Purchased -400 165.0000 American 19 Jul 2019
ADR Put Options Purchased -200 65.0000 American 17 Jan 2020
ADR Put Options Purchased -100 148.0000 American 14 Dec 2018
ADR Put Options Purchased -100 195.0000 American 15 Jan 2021
ADR Put Options Purchased -100 168.0000 American 14 Dec 2018
ADR Put Options Purchased -100 75.0000 American 17 Jan 2020
ADR Put Options Written 100 110.0000 American 17 Jan 2020
ADR Put Options Written 100 110.0000 American 18 Jan 2019
ADR Put Options Written 100 95.0000 American 18 Jan 2019
ADR Put Options Written 200 100.0000 American 18 Jan 2019
ADR Put Options Written 200 200.0000 American 17 Jan 2020
ADR Put Options Written 500 173.0000 American 14 Dec 2018
ADR Put Options Written 900 175.0000 American 21 Dec 2018
ADR Put Options Written 1,000 140.0000 American 21 Dec 2018
ADR Put Options Written 1,000 150.0000 American 21 Dec 2018
ADR Put Options Written 1,000 147.0000 American 28 Dec 2018
ADR Put Options Written 1,000 90.0000 American 18 Jan 2019
ADR Put Options Written 1,200 150.0000 American 18 Apr 2019
ADR Put Options Written 1,800 185.0000 American 18 Jan 2019
ADR Put Options Written 2,300 130.0000 American 18 Jan 2019
ADR Put Options Written 2,900 150.0000 American 18 Jan 2019
ADR Put Options Written 4,000 165.0000 American 18 Apr 2019
ADR Put Options Written 5,300 120.0000 American 18 Jan 2019
ADR Put Options Written 6,900 170.0000 American 18 Apr 2019
ADR Put Options Written 10,500 155.0000 American 21 Dec 2018
ADR Put Options Written 11,000 160.0000 American 19 Jul 2019
ADR Put Options Written 14,800 155.0000 American 18 Apr 2019
ADR Put Options Written 15,200 165.0000 American 21 Dec 2018
ADR Put Options Written 20,300 165.0000 American 18 Jan 2019
ADR Put Options Written 27,500 160.0000 American 21 Dec 2018
ADR Put Options Written 29,300 125.0000 American 18 Jan 2019
ADR Put Options Written 46,400 160.0000 American 18 Jan 2019
ADR Put Options Written 157,900 145.0000 American 21 Dec 2018
ADR Put Options Written 279,200 145.0000 American 18 Jan 2019

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181218005486/en/

Copyright Business Wire 2018

12345678910
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.